GNH USA

Europe — EMA

Liprolog Junior Kwikpen

GNH USA supplies Liprolog Junior Kwikpen (Insulin Lispro), a rapid‑acting insulin analog for Type 1 and Type 2 diabetes. Request a quote for quick supply.

Insulin Lispro

Request sourcing

1
Pack/s

What is Insulin Lispro?

Insulin Lispro, the active ingredient in Liprolog Junior Kwikpen, is a rapid‑acting insulin analog presented as a solution for injection (pre‑filled pen) for subcutaneous use. It treats diabetes mellitus in both type 1 and type 2 patients.

GNH USA supplies Liprolog Junior Kwikpen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Insulin Lispro used for?

Insulin Lispro is a rapid‑acting insulin analog used to manage blood glucose in diabetes mellitus.

- Type 1 diabetes mellitus: provides mealtime glucose control to reduce hyperglycemia. - Type 2 diabetes mellitus (as adjunct therapy): improves post‑prandial glucose levels when combined with oral agents. - Diabetes mellitus (general): offers rapid reduction of elevated blood glucose after meals.

What are the side effects of Insulin Lispro?

Common Side Effects: - Hypoglycemia (low blood sugar) - Injection site pain or erythema - Lipohypertrophy at injection sites - Mild allergic skin reactions

Serious or Rare Side Effects: - Severe hypoglycemia leading to loss of consciousness - Anaphylactic reaction - Edema - Hypersensitivity with bronchospasm

What precautions apply to Insulin Lispro?

Precautions should be taken when using Liprolog Junior Kwikpen. - Dose individualization: adjust based on blood glucose monitoring and carbohydrate intake. - Hypoglycemia risk: monitor for signs and have a rapid‑acting carbohydrate source available. - Renal impairment: may require dose reduction. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Drug interactions: review concomitant medications that affect glucose levels. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Insulin Lispro interact with?

Insulin Lispro may interact with several medicines.

Major Interactions (Avoid): - Concurrent use of sulfonylureas: increased hypoglycemia risk. - Beta‑blockers: may mask hypoglycemia symptoms. - Systemic corticosteroids: may require higher insulin dose.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may enhance insulin sensitivity, monitor glucose. - Thiazide diuretics: may raise blood glucose, monitor levels. - Alcohol: can cause delayed hypoglycemia, advise caution.

Frequently asked questions

What is Liprolog Junior Kwikpen used for?+
Liprolog Junior Kwikpen is a pre‑filled pen containing insulin lispro, a rapid‑acting insulin analog used to control post‑prandial blood glucose in patients with type 1 diabetes and in type 2 diabetes when additional insulin is required.
How does insulin lispro work?+
Insulin lispro mimics natural insulin but binds more quickly to insulin receptors. It rapidly stimulates glucose uptake into muscle and fat cells and suppresses liver glucose output, providing fast reduction of blood sugar after meals.
What is the usual dose of Liprolog Junior Kwikpen?+
The dose of insulin lispro is individualized. A qualified prescriber determines the amount, timing, and frequency based on the patient’s blood‑glucose readings, carbohydrate intake, and overall treatment plan.
Is Liprolog Junior Kwikpen safe in pregnancy or breastfeeding?+
Data on insulin lispro use during pregnancy and lactation are limited. It may be used only when the expected benefit to the mother outweighs any potential risk to the fetus or infant, and under close medical supervision.
How do I order Liprolog Junior Kwikpen from GNH USA?+
Submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, cold‑chain shipping details, and necessary import documentation.
How does Liprolog Junior Kwikpen compare with regular human insulin?+
Compared with regular (short‑acting) human insulin, insulin lispro has a faster onset of action and a shorter duration, allowing more flexible mealtime dosing and reduced risk of post‑prandial hyperglycemia. Both require careful monitoring for hypoglycemia.
What are the storage and handling requirements for Liprolog Junior Kwikpen?+
Store the pen at 2‑8 °C (refrigerated) in its original carton, protected from light. Do not freeze or shake the pen. If needed, it can remain at controlled room temperature (up to 30 °C) for up to 28 days, but refrigeration is preferred for potency.
How is Liprolog Junior Kwikpen administered?+
The pen is designed for subcutaneous injection. After attaching a new needle, the user primes the pen, selects the prescribed dose, and injects into the abdomen, thigh, or upper arm at a 90° angle, rotating sites with each use.
What are the most serious risks to watch for when using Liprolog Junior Kwikpen?+
The most serious risks include severe hypoglycemia, which can cause loss of consciousness or seizures, and rare allergic reactions such as anaphylaxis. Patients should be educated to recognize early symptoms and have rapid‑acting glucose on hand.
Who should not use Liprolog Junior Kwikpen?+
Individuals with a known hypersensitivity to insulin lispro or any component of the formulation should avoid its use. Caution is also advised for patients with severe renal or hepatic impairment, and it should not be used without medical supervision in pregnant or lactating women unless deemed necessary.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Insulin Lispro
Route
Intravenous Use , Subcutaneous Use
Manufacturer
Eli Lilly Nederland B.V.
Origin
EU

Related products